Free Trial
NYSE:EHAB

Enhabit (EHAB) Stock Price, News & Analysis

Enhabit logo
$13.78 +0.02 (+0.11%)
As of 01:54 PM Eastern
This is a fair market value price provided by Massive. Learn more.

About Enhabit Stock (NYSE:EHAB)

Advanced

Key Stats

Today's Range
$13.78
$13.80
50-Day Range
$13.58
$14.08
52-Week Range
$6.47
$14.22
Volume
224,289 shs
Average Volume
1.20 million shs
Market Capitalization
$706.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.57
Consensus Rating
Hold

Company Overview

Enhabit Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

EHAB MarketRank™: 

Enhabit scored higher than 37% of companies evaluated by MarketBeat, and ranked 694th out of 860 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Enhabit has received a consensus rating of Hold. The company's average rating score is 2.11, and is based on no strong buy ratings, 2 buy ratings, 6 hold ratings, and 1 sell rating.

  • Upside/Downside

    The consensus price target for Enhabit is close to its current price, suggesting limited near-term upside or downside.

  • Amount of Analyst Coverage

    Enhabit has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Enhabit's stock forecast and price target.
  • Earnings Growth

    Earnings for Enhabit are expected to grow by 7.41% in the coming year, from $0.54 to $0.58 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Enhabit is -153.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Enhabit is -153.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Enhabit has a P/B Ratio of 1.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    2.76% of the float of Enhabit has been sold short.
  • Short Interest Ratio / Days to Cover

    Enhabit has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Enhabit has recently increased by 1.25%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Enhabit does not currently pay a dividend.

  • Dividend Growth

    Enhabit does not have a long track record of dividend growth.

  • News Sentiment

    Enhabit has a news sentiment score of 1.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for Enhabit this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Enhabit insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $57,163.00 in company stock.

  • Percentage Held by Insiders

    3.40% of the stock of Enhabit is held by insiders.

  • Percentage Held by Institutions

    Enhabit has minimal institutional ownership at this time.

  • Read more about Enhabit's insider trading history.
Receive EHAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enhabit and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

EHAB Stock News Headlines

Elon’s Biggest Launch Ever: 15x Bigger Than SpaceX
The Man Who Called Nvidia Before It Soared 1,000% Issues New Elon Musk BUY Alert Luke Lango was ranked America's #1 stock picker in 2020. He was mentored by two hedge fund billionaires from the Soros network and trained at Caltech. His readers have had the chance to see gains as high as AMD +8,500%... Nvidia +5,000%... Tesla +3,500%... Palantir +1,000%... and Apple +890%.tc pixel
Enhabit, Inc
See More Headlines

EHAB Stock Analysis - Frequently Asked Questions

Enhabit's stock was trading at $9.22 at the beginning of the year. Since then, EHAB shares have increased by 49.5% and is now trading at $13.7850.

Enhabit, Inc. (NYSE:EHAB) issued its quarterly earnings results on Thursday, March, 5th. The company reported $0.14 earnings per share for the quarter, hitting analysts' consensus estimates of $0.14. The business had revenue of $270.40 million for the quarter, compared to analyst estimates of $270.56 million. Enhabit had a positive trailing twelve-month return on equity of 4.71% and a negative net margin of 0.43%.

Enhabit's top institutional investors include Dimensional Fund Advisors LP (2.91%), Hsbc Holdings PLC (1.70%), West Tower Group LLC (0.70%) and Bank of New York Mellon Corp (0.44%). Insiders that own company stock include Ryan Solomon, Julie Diane Jolley, Jeffrey Bolton, Stuart M Mcguigan, Ronald Leroy Langham Jr, L Edward Shaw Jr, Erin Hoeflinger and Collin Mcquiddy.
View institutional ownership trends
.

Shares of EHAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Enhabit investors own include Alphabet (GOOG), Tesla (TSLA), JPMorgan Chase & Co. (JPM), Advanced Micro Devices (AMD), Netflix (NFLX), Home Depot (HD) and Meta Platforms (META).

Company Calendar

Last Earnings
3/05/2026
Today
5/08/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Medical Services
Sub-Industry
Healthcare
Current Symbol
NYSE:EHAB
CIK
1803737
Fax
N/A
Employees
10,800
Year Founded
N/A

Price Target and Rating

High Price Target
$14.00
Low Price Target
$12.00
Potential Upside/Downside
-1.5%
Consensus Rating
Hold
Rating Score (0-4)
2.11
Research Coverage
9 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.09)
Trailing P/E Ratio
N/A
Forward P/E Ratio
25.53
P/E Growth
N/A
Net Income
-$4.60 million
Net Margins
-0.43%
Pretax Margin
0.13%
Return on Equity
4.71%
Return on Assets
2.23%

Debt

Debt-to-Equity Ratio
0.76
Current Ratio
1.63
Quick Ratio
1.63

Sales & Book Value

Annual Sales
$1.06 billion
Price / Sales
0.67
Cash Flow
$1.96 per share
Price / Cash Flow
7.02
Book Value
$11.05 per share
Price / Book
1.25

Miscellaneous

Outstanding Shares
51,230,000
Free Float
49,484,000
Market Cap
$706.21 million
Optionable
Optionable
Beta
1.26
The 10 Best High-Yield Dividend Stocks for 2026 Cover

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

This page (NYSE:EHAB) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners